We narrowed to 20,897 results for: Cre
-
Plasmid#21189PurposeRosa26 knock-in vector for Cre-regulated cDNA expression and RNAi in transgenic miceDepositorInsertGateWay conversion cassette
ExpressionMammalianAvailable SinceSept. 2, 2009AvailabilityAcademic Institutions and Nonprofits only -
p155 pCMV-EGFP/beta-gal
Plasmid#8387DepositorInsertfloxed EGFP
UseCre/Lox; Beta-galExpressionMammalianAvailable SinceAug. 4, 2006AvailabilityAcademic Institutions and Nonprofits only -
p133 pSV-STOP-luc
Plasmid#8390DepositorInsertfloxed STOP
UseCre/Lox and LuciferaseExpressionMammalianAvailable SinceMay 24, 2006AvailabilityAcademic Institutions and Nonprofits only -
MSCV FLIP FF
Plasmid#19744DepositorInsertoligo targeting Firefly luciferase
UseCre/Lox, RNAi, and RetroviralExpressionMammalianAvailable SinceDec. 18, 2008AvailabilityAcademic Institutions and Nonprofits only -
LCMV:ECFP(loxP)(FRT)EYFP
Plasmid#31304DepositorInsertECFP(loxP)(FRT)EYFP
UseCre/Lox; Flp/frtExpressionMammalianAvailable SinceOct. 14, 2011AvailabilityAcademic Institutions and Nonprofits only -
pL3-TRE-MCS-polyA-2L
Plasmid#11719DepositorTypeEmpty backboneUseCre/LoxExpressionMammalianAvailable SinceMay 4, 2006AvailabilityAcademic Institutions and Nonprofits only -
LCMV:ECFP(loxP)EYFP
Plasmid#31306DepositorInsertECFP(loxP)EYFP
UseCre/LoxExpressionMammalianAvailable SinceOct. 14, 2011AvailabilityAcademic Institutions and Nonprofits only -
pTLOX
Plasmid#12513DepositorTypeEmpty backboneUseCre/LoxExpressionMammalianAvailable SinceNov. 13, 2006AvailabilityAcademic Institutions and Nonprofits only -
p144 pSV-EGFP/beta-gal
Plasmid#8386DepositorInsertfloxed EGFP
UseCre/Lox; Beta-galExpressionMammalianAvailable SinceJuly 18, 2006AvailabilityAcademic Institutions and Nonprofits only -
p169 pCMV/betaAc-EGFP/beta-gal
Plasmid#8388DepositorInsertfloxed EGFP beta-gal
UseCre/Lox; Beta-galExpressionMammalianAvailable SinceApril 28, 2006AvailabilityAcademic Institutions and Nonprofits only -
50_p5E_UBI_loxTagBFP
Plasmid#172518Purposep5E tol2kit compatible clone encoding a Ubiquitin promoter and a tagBFP sequence terminated by 3x polyA sequences and flanked by floxP sites for CRE-excisionDepositorInsertubiquitin promoter, TagBFP, loxP sites (inversion)
PromoterUbiquitinAvailable SinceJan. 23, 2023AvailabilityAcademic Institutions and Nonprofits only -
pENN.AAV.hSyn.HI.eGFP-Cre.WPRE.SV40 (AAV Retrograde)
Viral Prep#105540-AAVrgPurposeReady-to-use AAV Retrograde particles produced from pENN.AAV.hSyn.HI.eGFP-Cre.WPRE.SV40 (#105540). In addition to the viral particles, you will also receive purified pENN.AAV.hSyn.HI.eGFP-Cre.WPRE.SV40 plasmid DNA. Expression of EGFP-Cre from hSyn promoter. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsEGFPAvailable SinceSept. 27, 2018AvailabilityAcademic Institutions and Nonprofits only -
pENN.AAV.hSyn.HI.eGFP-Cre.WPRE.SV40 (AAV PHP.eB)
Viral Prep#105540-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pENN.AAV.hSyn.HI.eGFP-Cre.WPRE.SV40 (#105540). In addition to the viral particles, you will also receive purified pENN.AAV.hSyn.HI.eGFP-Cre.WPRE.SV40 plasmid DNA. Expression of EGFP-Cre from hSyn promoter. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsEGFPAvailable SinceSept. 4, 2018AvailabilityAcademic Institutions and Nonprofits only -
pENN.AAV.CamKII.HI.GFP-Cre.WPRE.SV40 (AAV Retrograde)
Viral Prep#105551-AAVrgPurposeReady-to-use AAV Retrograde particles produced from pENN.AAV.CamKII.HI.GFP-Cre.WPRE.SV40 (#105551). In addition to the viral particles, you will also receive purified pENN.AAV.CamKII.HI.GFP-Cre.WPRE.SV40 plasmid DNA. Expression of GFP-Cre from CamKII promoter. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIITagsGFPAvailable SinceOct. 21, 2024AvailabilityAcademic Institutions and Nonprofits only -
HS_NAM-B1
Plasmid#154064PurposeLevel M, P1 Golden Gate vector. OsAct::Hyg-nosT/HvHSP17::Cre-hspT/ZmUbi::loxP-GUS-loxP-NAM-B1-nosTDepositorInsertsHygromycin phosphotransferase
Cre recombinase
LoxP-flanked GUS and TtNAM-B1
UseCre/Lox and Synthetic Biology; Golden gateExpressionBacterial and PlantMutationThe TtNAM-B1 gene sequence was domesticated to re…PromoterHvHSP17, OsAct, and ZmUbiAvailable SinceSept. 30, 2020AvailabilityAcademic Institutions and Nonprofits only -
pENN.AAV.CamKII 0.4.Cre.SV40 (AAV9)
Viral Prep#105558-AAV9PurposeReady-to-use AAV9 particles produced from pENN.AAV.CamKII 0.4.Cre.SV40 (#105558). In addition to the viral particles, you will also receive purified pENN.AAV.CamKII 0.4.Cre.SV40 plasmid DNA. CamKII-driven Cre expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIIAvailable SinceJuly 30, 2018AvailabilityAcademic Institutions and Nonprofits only -
pENN.AAV.CamKII 0.4.Cre.SV40 (AAV1)
Viral Prep#105558-AAV1PurposeReady-to-use AAV1 particles produced from pENN.AAV.CamKII 0.4.Cre.SV40 (#105558). In addition to the viral particles, you will also receive purified pENN.AAV.CamKII 0.4.Cre.SV40 plasmid DNA. CamKII-driven Cre expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIIAvailable SinceMay 15, 2018AvailabilityAcademic Institutions and Nonprofits only -
pENN.AAV.CamKII 0.4.Cre.SV40 (AAV5)
Viral Prep#105558-AAV5PurposeReady-to-use AAV5 particles produced from pENN.AAV.CamKII 0.4.Cre.SV40 (#105558). In addition to the viral particles, you will also receive purified pENN.AAV.CamKII 0.4.Cre.SV40 plasmid DNA. CamKII-driven Cre expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIIAvailable SinceAug. 9, 2018AvailabilityAcademic Institutions and Nonprofits only -
pAAV-EF1a-iCreV (AAV1)
Viral Prep#140135-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-EF1a-iCreV (#140135). In addition to the viral particles, you will also receive purified pAAV-EF1a-iCreV plasmid DNA. EF1a-driven, light-inducible iCreV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceSept. 15, 2021AvailabilityAcademic Institutions and Nonprofits only -
pAAV-EF1a-C-CreintG (AAV1)
Viral Prep#69571-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-EF1a-C-CreintG (#69571). In addition to the viral particles, you will also receive purified pAAV-EF1a-C-CreintG plasmid DNA. EF1a-driven expression of optimized C-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-N-CretrcintG (Addgene catalog# 69570) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceFeb. 19, 2020AvailabilityAcademic Institutions and Nonprofits only